TITLE

The Role of Etiology in the Hyperamylasemia of Acute Liver Failure

AUTHOR(S)
Coté, Gregory A.; Gottstein, Jeanne H.; Daud, Amna; Blei, Andres T
PUB. DATE
March 2009
SOURCE
American Journal of Gastroenterology;Mar2009, Vol. 104 Issue 3, p592
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVES:Hyperamylasemia (HA) is often reported in patients with acute liver failure (ALF). Direct toxic effects of acetaminophen on the pancreas have been postulated, but the occurrence of HA in other etiologies raises the question of whether multiorgan failure is part of the pathogenesis of HA in this setting. Our main aim was to describe and analyze the incidence, clinical characteristics, and outcomes of HA in ALF of different etiologies.METHODS:Patients enrolled in the Acute Liver Failure Study Group registry with an admission amylase value available were included. For the purpose of this analysis, HA was defined as ≥3× upper limits of normal. Patients were classified as having acetaminophen (APAP)- or non-APAP-induced ALF, and by amylase group: normal (<115), mildly elevated (115–345), or HA (>345). Significant variables identified by univariate analysis were added to a multiple linear regression model. The primary outcome was overall survival.RESULTS:In total, 622 eligible patients were identified in the database, including 287 (46%) with APAP-induced ALF; 76 (12%) patients met the criteria for HA. Among patients with HA, 7 (9%) had documented clinical pancreatitis. The incidence of HA was similar among APAP (13%) and non-APAP (12%) patients. Although HA was associated with renal failure and greater Model for End-stage Liver Disease scores for both groups, HA was not an independent predictor of mortality in multivariate analysis.CONCLUSIONS:Although not an independent predictor of mortality, HA in ALF was present in all etiologies and was associated with diminished overall survival. HA appeared to be related to renal dysfunction in both groups and multiorgan failure in non-APAP ALF.Am J Gastroenterol 2009; 104: 592–597; doi:10.1038/ajg.2008.84; published online 17 February 2009
ACCESSION #
36803378

 

Related Articles

  • Estimating the Impact of the Discontinuation of Medical Interventions on Health Outcomes.  // American Journal of Epidemiology;Mar2009, Vol. 169 Issue 6, p653 

    The same study designs are used to document the magnitude of the influence of currently used and of previously used treatments on health outcomes. However, because randomized trials rarely are utilized to study cessation of treatment, most of what we know about the experience of former users of...

  • Sphenoid mucocele: a rare cause of ocular dysfunction. Hill, C.; Kumar, G.; Virk, J.S.; Owa, A.; Kaddour, H. // QJM: An International Journal of Medicine;Jun2014, Vol. 107 Issue 6, p463 

    No abstract available.

  • Why TKAs Fail. MAKHNI, ERIC C.; DY, CHRISTOPHER J. // AAOS Now;Jun2014, Vol. 8 Issue 6, p24 

    The article reports on the contribution of continual review of data sources to the determination of common etiologies of total knee arthroplasty (TKA) failure. It discusses the value of these sources, including clinical trials, administrative claims, and registry data. It notes that the...

  • Clinical presentation of Puumala virus infections in southern Austria in the peak year 2012. Fabian, E.; Valentin, T.; Hoenigl, M.; Krause, R.; Zollner-Schwetz, I. // European Journal of Clinical Microbiology & Infectious Diseases;Apr2014, Vol. 33 Issue 4, p587 

    In 2012, an extraordinary rise in Puumala infections causing nephropathia epidemica (NE) was observed in southern Austria. We investigated differences in epidemiology, clinical presentation, laboratory results, treatment parameters, and outcome between patients in 2012 and previous years...

  • Recent perspectives on mechanisms of liver fibrogenesis : microRNA and cell autophagy. GUO, Jinsheng // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;May2013, Vol. 29 Issue 5, p324 

    Liver fibrogenesis remains a significant outcome of chronic liver disease and etiologic factors of progression to end - stage liver cir-rhosis. In recent years, the collective research efforts on the cellular and molecular mechanisms underlying this pathogenic condition have uncovered important...

  • Validation of the Brazilian version of Chronic Liver Disease Questionnaire. Mucci, Samantha; Albuquerque Citero, Vanessa; Gonzalez, Adriano; Geocze, Luciana; Geocze, Stephan; Jesus Lopes Filho, Gaspar; Marco, Mario; Parise, Edison; Martins, Luiz // Quality of Life Research;Feb2013, Vol. 22 Issue 1, p167 

    Purpose: The aim of this study was to validate the Chronic Liver Disease Questionnaire (CLDQ) for use in Brazilian population. Method: A total of 200 patients with chronic liver disease and varying disease severity answered a socio-demographic questionnaire, t CLDQ, and the Medical Outcome Study...

  • Genetic variation in inflammasome genes is associated with outcome in bacterial meningitis. Geldhoff, Madelijn; Mook-Kanamori, Barry; Brouwer, Matthijs; Valls Seron, Mercedes; Baas, Frank; Ende, Arie; Beek, Diederik // Immunogenetics;Jan2013, Vol. 65 Issue 1, p9 

    Bacterial meningitis is a severe and deadly disease, most commonly caused by Streptococcus pneumoniae. Disease outcome has been related to severity of the inflammatory response in the subarachnoid space. Inflammasomes are intracellular signaling complexes contributing to this inflammatory...

  • Loss of Lordosis and Clinical Outcomes after Anterior Cervical Fusion with Dynamic Rotational Plates. Jin-Young Lee; Moon Soo Park; Seong-Hwan Moon; Jae-Hyuk Shin; Seok Woo Kim; Yong-Chan Kim; Seong Jin Lee; Bo-Kyung Suh; Hwan-Mo Lee // Yonsei Medical Journal;May2013, Vol. 54 Issue 3, p726 

    Purpose: The cervical dynamic rotational plating system may induce bone graft subsidence, so it may cause loss of cervical lordosis. However there were few studies for alignments of cervical spines influencing the clinical results after using dynamic rotational plates. The purpose is to evaluate...

  • Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function. Kim, Jeong; Ryoo, Baek-Yeol; Ryu, Min-Hee; Chang, Heung-Moon; Suh, Dong; Lee, Han; Lim, Young-Suk; Kim, Kang; Kang, Yoon-Koo // Cancer Chemotherapy & Pharmacology;Nov2011, Vol. 68 Issue 5, p1285 

    Purpose: We compared the efficacy and safety of sorafenib in patients with Child-Pugh (CP) class B and CP class A. Methods: Clinical data from 267 patients with HCC who had been treated with sorafenib were reviewed. Patients were grouped according to CP score (5-6, 7, and 8-9), and their tumor...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics